Search

everythinglearnresearchcommunity

for

Search:↓

Researchers created a new mouse model for studying Citrullinemia Type I and similar conditions, showing symptoms and treatment responses like those in humans.

Metastatic cervical cancer can cause rare, severe Cushing's syndrome with high risk of death.

Cyclophosphamide can cause serious short-term and long-term side effects, including increased cancer risk and infertility.

Rapid virilization should be checked for possible ovarian or adrenal cancer.

A patient with Ivemark syndrome developed mixed type vitiligo after a hepatitis C infection, showing different treatment responses and immune cell involvement in the skin.

Correct diagnosis and treatment are crucial for effective management of lipid storage myopathies.

A man with Cronkhite-Canada syndrome improved significantly with immunosuppressive therapy.

Drug misuse can cause serious eye infections and other severe side effects.

Recurrent NICF is a rare skin condition with unclear causes, involving follicle inflammation and crystal deposits.

Lack of Cisd2 disrupts calcium balance in cells, leading to poorly functioning neutrophils.

Both penicillamine and tiopronin have significant side effects, but trying the alternative drug can be beneficial if the first is not tolerated.

Cri-du-chat syndrome can cause skin and oral lesions affecting nutrition and quality of life.

Corticosteroids improved symptoms in a man with Cronkhite-Canada Syndrome.

Two patients with Cronkhite-Canada syndrome achieved remission after treatment.

MC-DNA vector-based gene therapy can temporarily treat CBS deficiency in mice.

Azithromycin can rarely cause a severe drop in white blood cells.

Pegylated interferon-alpha 2a can cause a rare nerve disorder, but early treatment can lead to full recovery.

Cyproterone acetate effectively treats virilized women, especially under 35, despite some side effects.

Stilbamidine and hydroxystilbamidine inhibit enzyme release from lysosomes and have effects similar to cortisol and chloroquine.

Surgical excision is the best treatment for SCC, but intralesional cidofovir might be a good alternative.

Sweet syndrome can be the only sign of hairy cell leukemia relapse.

A cancer patient died from a severe skin reaction after taking the drug cetuximab.

Checkpoint inhibitor therapy can cause skin issues, from mild rashes to severe reactions.

The review suggests thorough evaluation and genetic testing for proper diagnosis and treatment of Chrousos syndrome.

Ruxolitinib may effectively treat APS-1 by reducing harmful immune responses.

Cetuximab can cause skin cysts after acne-like eruptions.

Clq deficiency is linked to systemic lupus erythematosus symptoms.

L-Cysteine may have health benefits, but its effectiveness is still debated due to limited clinical trial data.

Some leukemia treatments can cause skin reactions similar to keratosis pilaris.